Literature DB >> 27166031

p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: A study of 208 cases.

Juan C Cuevas Gonzalez1, Luis A Gaitan Cepeda1, Socorro A Borges Yanez2, Alejandro Donohue Cornejo3, Ana D Mori Estevez4, Elba Rosa Leyva Huerta1.   

Abstract

BACKGROUND: The use of p16 and p53 as biomarkers of malignant transformation of oral epithelial dysplasia (OED) and biological behavior of oral squamous cell carcinoma (OSCC) is controversial. AIM: To determine the immunoexpression of p16 and p53 in OED and OSCC and to establish their possible relation to histopathological grading of OED/OSCC.
MATERIALS AND METHODS: Ninety-six OEDs (40 mild, 36 moderate, and 20 severe dysplasia); and 112 OSCCs (64 well-differentiated, 38 moderately differentiated, and 10 poorly differentiated) coming from archives of four centers of oral pathology were included. Histological slides from all cases were processed with immunohistochemical technique using anti-p53 and anti-p16 antibodies. The intensity of the immunoreactivity were classified using the ImageLab®MCM systemas follows: <60 mild, >60-<90 moderate, and >90 strong. Forstatistical purposesa χ2 test (P < 0.05) was performed.
RESULTS: Severe dysplasia show highest relative frequency of p16-positive (35.5%), whereas p53 is associated with mild dysplasia (P = 0.04). Moderately differentiated OSCC had larger relative frequency of p16-positive and p53-positive cases (47.3% both circumstances) (P > 0.05). Statistical association of p16-positive and p53-positive cells to basal stratum of OED (P = 0.0008; P = 0.0000, respectively) and p16-positive cells and p53-positive cells to perivascular zone of OSCC (P = 0.001; P = 0.0000, respectively) was found.
CONCLUSIONS: p16 and p53 could be not specific enough to identify patients suffering OED with high risk to malignancy; however, the evaluation of the presence of p16 and p53 in the tumoral invasive front of OSCC could contribute to establish the tumor progression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27166031     DOI: 10.4103/0377-4929.182037

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

Review 1.  Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention.

Authors:  Sharmistha Dey; Abhay Kumar Singh; Abhinay Kumar Singh; Kartik Rawat; Joyita Banerjee; Vertica Agnihotri; Deepak Upadhaya
Journal:  Med Oncol       Date:  2022-01-20       Impact factor: 3.064

Review 2.  mTOR Signalling in Head and Neck Cancer: Heads Up.

Authors:  Fiona H Tan; Yuchen Bai; Pierre Saintigny; Charbel Darido
Journal:  Cells       Date:  2019-04-09       Impact factor: 6.600

3.  Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx.

Authors:  Priyanka Yadav; Reeni Malik; Sharda Balani; Rajendra Kumar Nigam; Pramila Jain; Puneet Tandon
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

4.  p53 Overexpression in Oral Mucosa in Relation to Shisha Smoking in Syria and Lebanon

Authors:  Khaled Zaid; Elie Azar-Maalouf; Charif Barakat; Mansour Chantiri
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.